Clinical Trial Update: A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and effectiveness of infliximab (Remicade) in patients with pancreatic cancer–related cachexia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia
• Pancreatic Cancer

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Cachexia, Pancreatic Neoplasms | Phase 2 | Status: COMPLETED